No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves
No Effects Found
Masuda H, Hirota S, Ushiyama A, Hirata A, Arima T, Watanabe H, Wake K, Watanabe S, Taki M, Nagai A, Ohkubo C ·2015
Share:
Local RF exposure to rat cortex at non-thermal levels did not produce observable changes in cerebral microcirculation or evidence of blood-brain barrier disruption.
Plain English Summary
Summary written for general audiences
This study examined whether exposure to 1439 MHz radiofrequency electromagnetic fields at 2.0 W/kg would alter cerebral microcirculatory parameters in rats under non-thermal conditions. The researchers measured three microcirculatory parameters related to cerebral inflammation in real-time during local cortex exposure and found no significant changes in blood flow velocity, vessel diameter, dye extravasation, or histological evidence of tissue damage.
Cite This Study
Masuda H, Hirota S, Ushiyama A, Hirata A, Arima T, Watanabe H, Wake K, Watanabe S, Taki M, Nagai A, Ohkubo C (2015). No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves.
Show BibTeX
@article{masuda_h_hirota_s_ushiyama_a_hirata_a_arima_t_watanabe_h_wake_k_watanabe_s_taki_m_nagai_a_ohkubo_c_ce3373,
author = {Masuda H and Hirota S and Ushiyama A and Hirata A and Arima T and Watanabe H and Wake K and Watanabe S and Taki M and Nagai A and Ohkubo C},
title = {No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves},
year = {2015},
doi = {10.1038/hr.2015.104},
}
This appears to be a database categorization error. The study examined combinations of cardiovascular drugs (benidipine with ARB, beta-blockers, or thiazide) and their effects on blood pressure variability, with no electromagnetic field exposure involved.
This study didn't examine EMF sensitivity at all. It focused solely on how different blood pressure medication combinations (benidipine-thiazide vs benidipine-beta-blocker vs benidipine-ARB) affected visit-to-visit blood pressure variability in cardiovascular patients.
This study provides no information about EMF protection. It was a cardiovascular medication trial comparing the effectiveness of different drug combinations in reducing blood pressure variability, completely unrelated to electromagnetic field exposure.
While blood pressure variability is an important health metric that could theoretically be studied in EMF research, this particular study only examined pharmaceutical interventions and provides no EMF-related data or insights.
This study offers no guidance for EMF-sensitive individuals. It was a standard pharmaceutical trial comparing medication effectiveness for blood pressure control, with no consideration of electromagnetic field exposure or sensitivity.
